Cost-effectiveness of insulin glargine compared to other long-acting basal insulins in the treatment of Finnish type 1 and type 2 diabetes patients based on individual studies
Finna-arvio
Cost-effectiveness of insulin glargine compared to other long-acting basal insulins in the treatment of Finnish type 1 and type 2 diabetes patients based on individual studies
Tallennettuna:
Kieli |
englanti |
---|---|
Tiivistelmän kieli |
suomi |
Luokitus | |
Aiheet/asiasanat |